Drug
Gen3018
Gen3018: highest development phase Phase 1, developed by Genmab. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Genmab
Trials
| Drug | Phase | Indication |
|---|---|---|
| GEN3018 NCT07384715 | Phase 1 | R/R AML |
Latest
No recent events.
Follow Gen3018 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.